Cidara Therapeutics Inc (CDTX) - Financial and Strategic SWOT Analysis Review

Market: Pharmaceuticals and Healthcare

United States, 25 pages report, published by GlobalData

Report ThumbnailAugust-2017
Summary

Cidara Therapeutics Inc (Cidara), formerly K2 Therapeutics Inc is a biotechnology company that discovers, develops and commercializes novel anti-infectives including immunotherapies. The company's pipeline products include novel echinocandin CD101 IV, for the treatment of systemic candida infections; CD101 topical, for prevention of vulvovaginal candidiasis and recurrent VVC; CD201, a bispecific antimicrobial immunotherapy that is being developed for multi-drug resistant bacterial infec

Read More
  • List of Figures
  • Cidara Therapeutics Inc, Performance Chart
  • Cidara Therapeutics Inc, Ratio Charts
Read More
  • List of Tables
  • Cidara Therapeutics Inc, Key Information
  • Cidara Therapeutics Inc, Key Ratios
  • Cidara Therapeutics Inc, Share Data
  • Cidara Therapeutics Inc, Major Products and Services
  • Cidara Therapeutics Inc, History
  • Cidara Therapeutics Inc, Key Employees
  • Cidara Therapeutics Inc, Key Employee Biographies
  • Cidara Therapeutics Inc, Key Operational Heads
  • Cidara Therapeutics Inc, Other Locations
  • Cidara Therapeutics Inc, Subsidiaries
  • Cidara Therapeutics Inc, Key Manufact
Read More
  • Table of Contents
  • Section 1 - About the Company
  • Cidara Therapeutics Inc - Key Information
  • Cidara Therapeutics Inc - Overview
  • Cidara Therapeutics Inc - Key Employees
  • Cidara Therapeutics Inc - Key Employee Biographies
  • Cidara Therapeutics Inc - Key Operational Heads
  • Cidara Therapeutics Inc - Major Products and Services
  • Cidara Therapeutics Inc - History
  • Cidara Therapeutics Inc - Company Statement
  • Cidara Therapeutics Inc - Locations And Subsidiaries
  • Cidara Therape
Read More

Please select a license type

Share

Related Products

GlobalDataCidara Therapeutics Inc (CDTX) - Financial and Strategic SWOT Analysis ReviewProduct ThumbnailCidara Therapeutics Inc (CDTX) - Financial and Strategic SWOT Analysis Review, Company ReportProduct #: 679728
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2017 Global Market Analyst. All Rights Reserved